EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Hemoadsorption: consensus report of the 30th Acute Disease Quality Initiative workgroup

Rinaldo Bellomo iD, Ghada Ankawi, Sean M Bagshaw, Ian Baldwin, Rajit Basu, Gabriella Bottari, Vincenzo Cantaluppi, William Clark, Silvia De Rosa, Lui G Forni, Dana Fuhrman, Stuart Goldstein und 22 weitere

Nephrology Dialysis Transplantation · 27.11.2024 · 39 (12) · 1945-1964

DOI: 10.1093/ndt/gfae089 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 15.04.2024. Verfasst von Rinaldo Bellomo und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care, The University of Melbourne, Melbourne, Australia. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 127 Literaturangaben. Gefördert von: Baxter, Jafron Biomedical, BBraun Avitum.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adsorption-based extracorporeal therapies have been subject to technical developments and clinical application for close to five decades. More recently, new technological developments in membrane and sorbent manipulation have made it possible to deliver more biocompatible extracorporeal adsorption therapies to patients with a variety of conditions. There are several key rationales based on physicochemical principles and clinical considerations that justify the application and investigation of such therapies as evidenced by multiple ex vivo, experimental and clinical observations. Accordingly, unspecific adsorptive extracorporeal therapies have now been applied to the treatment of a wide array of conditions from poisoning to drug overdoses, to inflammatory states and sepsis, and acute or chronic liver and kidney failure. In response to the rapidly expanding knowledge base and increased clinical evidence, we convened an Acute Disease Quality Initiative consensus conference dedicated to such treatment. The data show that hemoadsorption has clinically acceptable short-term biocompatibility and safety, technical feasibility and experimental demonstration of specified target molecule removal. Pilot studies demonstrate potentially beneficial effects on physiology and larger studies of endotoxin-based hemoadsorption have identified possible target phenotypes for larger randomized controlled trials. Moreover, in a variety of endogenous and exogenous intoxications, removal of target molecules has been confirmed in vivo. However, some studies have raised concerns about harm, or failed to deliver benefits. Thus, despite many achievements, modern hemoadsorption remains a novel and experimental intervention with limited data, and a large research agenda.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HumansAcute DiseaseHemoperfusion

Stichwörter der Autor:innen

acute kidney injuryhaemodialysisinflammationplasma exchangesepsis

Autor:innen und Institutionen

  • Department of Critical Care, The University of Melbourne, Melbourne, Australia.
  • Department of Internal Medicine and Nephrology, Kind Abdulaziz University, Jeddah, Saudi Arabia.
  • Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta and Alberta Health Services, Edmonton, Canada.
  • Department of Intensive Care and Clinical Research, Austin Hospital Health, Melbourne, Australia.
  • Department of Critical Care Medicine, Luri Children's Hospital, Chicago, IL, USA.
  • Pediatric Intensive Care Unit, Children Hospital Bambino Gesù, IRCSS, Rome, Italy.

ORCID-Profile: Rinaldo Bellomo

Förderung

  • Baxter
  • Jafron Biomedical
  • BBraun Avitum
  • CytoSorbents
  • ExThera Medical
  • Nipro Corporation
  • SeaStar Medical
  • Spectral

Zitieren

APA

Bellomo, R., Ankawi, G., Bagshaw, S. M., Baldwin, I., Basu, R., Bottari, G., Cantaluppi, V., Clark, W., De Rosa, S., Forni, L. G., Fuhrman, D., Goldstein, S., Gomez, H., Husain-Syed, F., Joannidis, M., Kashani, K., Lorenzin, A., Mehta, R., Murray, P. T., …, & Zarbock, A. (2024). Hemoadsorption: consensus report of the 30th Acute Disease Quality Initiative workgroup. Nephrology Dialysis Transplantation, 39(12), 1945-1964. https://doi.org/10.1093/ndt/gfae089

Vancouver

Bellomo R, Ankawi G, Bagshaw SM, Baldwin I, Basu R, Bottari G, et al. Hemoadsorption: consensus report of the 30th Acute Disease Quality Initiative workgroup. Nephrology Dialysis Transplantation. 2024;39(12):1945-1964. doi:10.1093/ndt/gfae089

BibTeX
@article{Bellomo2024,
  author = {Bellomo, Rinaldo and Ankawi, Ghada and Bagshaw, Sean M and Baldwin, Ian and Basu, Rajit and Bottari, Gabriella and Cantaluppi, Vincenzo and Clark, William and De Rosa, Silvia and Forni, Lui G and Fuhrman, Dana and Goldstein, Stuart and Gomez, Hernando and Husain-Syed, Faeq and Joannidis, Michael and Kashani, Kianoush and Lorenzin, Anna and Mehta, Ravindra and Murray, Patrick T and Murugan, Ragi and Ostermann, Marlies and Pannu, Neesh and Premuzic, Vedran and Prowle, John and Reis, Thiago and Rimmelé, Thomas and Ronco, Claudio and Rosner, Mitch and Schneider, Antoine and See, Emily and Soranno, Danielle and Villa, Gianluca and Whaley-Connell, Adam and Zarbock, Alexander},
  title = {Hemoadsorption: consensus report of the 30th Acute Disease Quality Initiative workgroup},
  journal = {Nephrology Dialysis Transplantation},
  year = {2024},
  volume = {39},
  number = {12},
  pages = {1945--1964},
  doi = {10.1093/ndt/gfae089}
}
Kostenlos starten →